Stevenson, M. (Matt), Scope, Alison, Sutcliffe, Paul A., Booth, A., Slade, P., Parry, G., Saxon, D. and Kalthenthaler, E.. (2010) Group cognitive behavioural therapy for postnatal depression : a systematic review of clinical effectiveness, cost effectiveness and value of information analyses. Health Technology Assessment, Vol.14 (No.44). pp. 1-135. ISSN 1366-5278

Preview	Text WRAP_Sutcliffe_Group_cognitive_behavioural.pdf - Published Version Download (1242Kb) | Preview
Preview	Text (Coversheet) WRAP_Sutcliffe_Group_cognitive_behavioural_coversheet.pdf - Supplemental Material Download (50Kb) | Preview

Abstract

Background: Postnatal depression (PND) describes a wide range of distressing symptoms that can occur in women following childbirth. There is substantial evidence to support the use of cognitive behaviour therapy (CBT) in the treatment of depression, and psychological therapies are recommended by the National Institute for Health and Clinical Excellence as a first-line treatment for PND. However, access is limited owing to expense, waiting lists and availability of therapists. Group CBT may, therefore, offer a solution to these problems by reducing therapist time and increasing the number of available places for treatment. Objectives: To evaluate the clinical effectiveness and cost-effectiveness of group CBT compared with currently used packages of care for women with PND. Data sources: Seventeen electronic bibliographic databases were searched (for example MEDLINE, MEDLINE In-Process & Other Non-Indexed Citations, EMBASE, PsycINFO, etc.), covering biomedical, health-related, science, social science and grey literature (including current research). Databases were searched from 1950 to January 2008. In addition, the reference lists of relevant articles were checked and various health services’ related resources were consulted via the internet. Review methods: The study population included women in the postpartum period (up to 1 year), meeting the criteria of a standardised PND diagnosis using the Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition, or scoring above cut-off on the Edinburgh Postnatal Depression Scale (EPDS). No exclusion was made on the basis of the standardised depression screening/case finding instrument of standardised clinical assessment tool used to define PND. All full papers were read by two reviewers (AS and DS) who made independent decisions regarding inclusion or exclusion, and consensus, where possible, was obtained by meeting to compare decisions. In the event of disagreement, a third reviewer (EK) read the paper and made the decision. All data from included quantitative studies were extracted by one reviewer (AS) using a standardised data extraction form. All data from included qualitative studies were extracted by two reviewers (AS and AB) using a standardised data extraction form with disagreements resolved by discussion. Two different data extraction forms were used, one for the quantitative papers and a second for the qualitative papers. Results: Six studies met the inclusion criteria for the quantitative review. Three were randomised controlled trials (RCTs) and three were non-randomised trials. Two studies met the inclusion criteria for the qualitative review. These were both treatment evaluations incorporating qualitative methods. Only one study was deemed appropriate for the decision problem; therefore a meta-analysis was not performed. This study indicated that the reduction in the EPDS score through group CBT compared with routine primary care (RPC) was 3.48 [95% confidence interval (CI) 0.23 to 6.73] at the end of the treatment period. At 6-month follow-up the relative reduction in EPDS score was 4.48 (95% CI 1.01 to 7.95). Three studies showed the treatment to be effective in reducing depression when compared to RPC, usual care or waiting list groups. There was no adequate evidence on which to assess group CBT compared with other treatments for PND. Two studies of group CBT for PND were included in the qualitative review. Both studies demonstrated patient acceptability of group CBT for PND, although negative feelings towards group CBT were also identified. A de novo economic model was constructed to assess the cost-effectiveness of group CBT. The base-case results indicated a cost per quality-adjusted life-year (QALY) of £46,462 for group CBT compared with RPC. The 95% CI for this ratio ranged from £37,008 to £60,728. There was considerable uncertainty in the cost per woman of running a CBT course, of the appropriateness of efficacy data to the decision problem, and the residual length of benefit associated with group CBT. These were tested using univariate sensitivity analyses. Supplementary analyses that fitted distributions to the cost of treatment and the duration of comparative advantage reported a cost per QALY of £36,062 (95% CI £20,464 to £59,262). Limitations The cost per QALY ratio for group CBT in PND was uncertain because of gaps in the evidence base. There was little quantitative or qualitative RCT evidence to assess the effectiveness of group CBT for PND. The evidence that was available was of low quality in the main because of poor reporting of the results. Furthermore, little information was reported on concurrent treatment used in the studies, which was controlled for in only two of the studies. Conclusions: Evidence from the clinical effectiveness review provided inconsistent and low quality information on which to base any interpretations for service provision. Although three of the included studies provided some indication that group psycho-education incorporating CBT is effective compared with RPC, there is enough doubt in the quality of the study, the level of CBT implemented in the group programmes, and the applicability to a PND population to limit any interpretations significantly. It is also considered that the place of group CBT in a stepped care programme needs to be identified, as well as there being a need for a clearer referral process for group CBT.

[error in script] [error in script]

Item Type:	Journal Article
Subjects:	R Medicine > R Medicine (General) R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry R Medicine > RG Gynecology and obstetrics
Divisions:	Faculty of Medicine > Warwick Medical School > Warwick Evidence Faculty of Medicine > Warwick Medical School > Health Sciences
Library of Congress Subject Headings (LCSH):	Postpartum depression -- Treatment -- Great Britain, Cognitive therapy -- Cost effectiveness, Cognitive therapy -- Great Britain, Medical care, Cost of -- Great Britain, Systematic reviews (Medical research)
Journal or Publication Title:	Health Technology Assessment
Publisher:	NIHR Health Technology Assessment programme
ISSN:	1366-5278
Date:	September 2010
Volume:	Vol.14
Number:	No.44
Number of Pages:	135
Page Range:	pp. 1-135
Identification Number:	10.3310/hta14440
Status:	Peer Reviewed
Publication Status:	Published
Access rights to Published version:	Restricted or Subscription Access
Funder:	NIHR Health Technology Assessment Programme (Great Britain)
References:	1. Milgrom J, Martin PR, Negri LM. Treating postnatal depression. A psychological approach for health care practitioners. England: Wiley; 1999. 2. Cox JL, Murray D, Chapman G. A controlled study of the onset, duration and prevalence of postnatal depression. Br J Psychiatry 1993;163:27–31. 3. World Health Organization. Tenth revision of the international classification of diseases and related health problems. Clinical descriptions and diagnostic guidelines. Geneva: WHO; 1992. 4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition. New York, NY: American Psychiatric Association; 1994. 5. National Institute for Health and Clinical Excellence. Antenatal and postnatal mental health: clinical management and service guidance (Brief record). London: NICE; 2007. 6. Jomeen J, Martin C. Confirmation of an occluded anxiety component within the Edinburgh Postnatal Depression Scale (EPDS) during early pregnancy. J Reprod Infant Psychol 2005;23:143–54. 7. National Institute for Health and Clinical Excellence, Scottish Executive Health Department, Department of Health, and Social Services and Public Safety, Northern Ireland. Why mothers die 1997–1999. The fifth report of the confidential enquiries into maternal deaths in the United Kingdom. London: RCOG Press; 2001. 8. Cooper P, Murray L. Course and recurrence of postnatal depression: Evidence for the specificity of the diagnostic concept. Br J Psychiatry 1995;166:191–5. 9. Cooper PJ, Murray L. Postnatal depression. BMJ 1998;316:1884–6. 10. Beck C. Predictors of postpartum depression: An update. Nurs Res 2001;50:275–85. 11. Robertson E, Grace S, Wallington T, Stewart D. Antenatal risk factors for postpartum depression: a synthesis of recent literature. Gen Hosp Psychiatry 2004;26:289–95. 12. Morrell CJ, Slade P, Warner R, Paley G, Dixon S, Walters SJ, et al. Clincial effectiveness of health visitor training in psychologically informed approaches for depression in postnatal women: pragmatic cluster randomised trial in primary care. BMJ 2009;338:1–10. 13. Morrell CJ, Warner R, Slade P, Dixon S, Walters S, Paley G, et al. Psychological interventions for postnatal depression: Cluster randomised trial and economic evaluation. The PoNDER trial. Health Technol Assess 2009;13(30). 14. Gaynes BN, Gavin N, Meltzer-Brody S, Lohr KN, Swinson T, Gartlehner G, et al. Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evid Rep Technol Assess (Summ) 2005:1–8. 15. O’Hara MW, Swain AM. Rates and risk of postpartum depression-a meta-analysis. Int Rev Psychiatry 1996;8:37–54. 16. Beck AT, Steer RA, Brown GK. Beck Depression Inventory Manual. San Antonio, TX: Psychological Corporation; 1996. 17. Wieck A, Kumar R, Hirst AD, Marks MN, Campbell IC, Checkley SA. Increased sensitivity of dopamine receptors and recurrence of affective psychosis after childbirth. BMJ 1991;303:613–16. 18. Beck CT. Postpartum depression: it isn’t just the blues. Am J Nurs 2006;106:40–50. 19. Kendell RE, Chalmers JC, Platz C. Epidemiology of puerperal psychoses. Br J Psychiatry 1987;150: 662–73. [Erratum published in Br J Psychiatry 1987;151:135.] 20. O’Hara M. The nature of postpartum depressive disorders. In Murray L, Cooper P, editors. Postpartum depression and child development. New York, NY: Guildford; 1997: 3–31. 21. Beck C. A meta-analysis of predictors of postpartum depression. Nurs Res 1996;45:297–303. 22. O’Hara M, Schlechte J, Lewis D, Wright E. Prospective study of postpartum blues: Biologic and psychosocial factors. Arch Gen Psychiatry 1991;48:801–6. 23. Cooper P, Murray L, Hooper R, West A. The development and validation of a predictive index for postpartum depression. Psychol Med 1996;26:627–34. 24. Murray L, Cooper P. The impact of postpartum depression on child development. Int Rev Psychiatry 1996;8:55–63. 25. Murray L. The impact of postnatal depression on infant development. J Child Psychol Psychiatry 1992;33:543–61. 26. Hay D, Pawlby S, Sharp D, Asten P, Mills A, Kumar R. Intellectual problems shown by 11-year-old children whose mothers had postnatal depression. J Child Psychol Psychiatry 2001;42:871–89. 27. Carter A, Garrity R, Chazan C, Little C, Briggs G. Maternal depression and comorbidity: Predicting early parenting, attachment security, and toddler social-emotional problems and competencies. J Am Acad Child Adolesc Psychiatry 2001;40:18–26. 28. Campbell SB, Cohn JF, Meyers T. Depression in first-time mothers – mother–infant interaction and depression chronicity. Dev Psychol 1995;31:349–57. 29. Escribe-Aguir V, Gonzalez-Galarzo MC, Barona-Vilar C, Artazcoz L. Factors related to depression during pregnancy: are there gender differences? J Epidemiol Community Health 2008;62:410–14. 30. Areias MEG, Kumar R, Barros H, Figueiredo E. Correlates of postnatal depression in mothers and fathers. Br J Psychiatry 1996;169:36–41. 31. Healthcare Commission towards better births. A review of maternity services in England. Service Review. London: Commission for Healthcare Audit and Inspection; 2008. 32. National Institute for Health and Clinical Excellence. Antenatal and postnatal mental health: Clinical management and service guidance. 2006. URL: www.nice.org.uk/nicemedia/pdf/ APMHConsFullGuideline.pdf (accessed 1 April 2009). 33. Appleby L, Warner R, Whitton AF, Faragher B. A controlled study of fluxetine and cognitivebehavioral counselling in the treatment of postnatal depression. BMJ 1997;314:932–6. 34. National Institute for Health and Clinical Excellence. Commissioning antenatal and postnatal mental health services. 2007. URL: www.nice.org. uk/usingguidance/commissioningguides/apmh.jsp (accessed 1 April 2009). 35. Family & Parenting Institute. Health visitors: A progress report. 2009. URL: www.familyandparenting. org/Filestore//Documents/Our_work/Campaigns/ HealthVisitors_a_progress_report.pdf (accessed 1 April 2009). 36. Dennis CL, Chung-Lee L. Postpartum depression help–seeking barriers and maternal treatment preferences: a qualitative systematic review. Birth 2006;33:323–31. 37. Royal College of Psychiatrists. Perinatal Maternal Mental Health Services. Council Report CR88. London: Royal College of Psychiatrists; 2000. 38. Curtis L. Unit costs of health and social care. Canterbury: University of Kent; 2007. 39. Department of Health. Treatment choice in psychological therapies and counselling. Evidence based clinical practice guideline. London: DoH; 2001. 40. National Institute for Health and Clinical Excellence. Depression (amended). Management of Depression in primary and secondary care. NICE Clinical Guideline 23 (amended). London: NICE; 2007. 41. Cuijpers P, van Straten A, Andersson G, van Oppen P. Psychotherapy for depression in adults: A meta-analysis of comparative outcome studies. J Consult Clin Psychol 2008;76:909–22. 42. Dennis CL, Hodnett E. Psychosocial and psychological interventions for treating postpartum depression. Cochrane Database Syst Rev 2007;CD006116. 43. Honey KLB. A brief psycho-educational group intervention for postnatal depression. Br J Clin Psychol 2002;41:405–9. 44. Ades AE, Cliffe S. Markov Chain Monte Carlo estimation of a multi-parameter decision model: consistency of evidence and the accurate assessment of uncertainty. Med Decis Making 2002;22:359–71. 45. Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001;10:779–87. 46. Claxton K, Posnett J. An economic approach to clinical trial design and research priority-setting. Health Econ 1996;5:513–24. 47. Ades AE, Lu G, Claxton K. Expected values of sample information calculation in medical decision making. Med Decis Making 2004;24:207–27. 48. Felli JC, Hazen JB. Sensitivity analysis and the expected value of perfect information. Med Decis Making 1998;18:95–109. 49. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression: Development of the 10- item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987;150:782–6. 50. Beck AT, Steer RA. Manual for the Beck Depression Inventory. San Antonio, TX: Psychological Corporation; 1993. 51. Centre for Reviews and Dissemination. Systematic reviews: CRD’s guidance for undertaking reviews in health care. University of York, York: CRD; 2009. 52. Davies S, Jasper M. A first-stage evaluation of a group programme for PND. Community Pract 2004;77:426–33. 53. Morgan M, Matthey S, Barnett B, Richardson C. A group programme for postnatally distressed women and their partners. J Adv Nurs 1997;26:913–20. 54. Deeks JJ, Dinnes J, D’Amico R, Sowden AJ, Sakarovitch C, Song F, et al. Evaluating nonrandomised intervention studies. Health Technol Assess 2003;7(27). 55. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodolgical quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998;52:377–84. 56. National CASP collaboration for qualitative methodologies. Critical Appraisal Skills Programme (CASP) making sense of evidence. 10 questions to help you make sense of qualitative research. England: Public Health Resource Unit; 2006. 57. Sandelowski M, Barroso J. Handbook for synthesizing qualitative research. New York, NY: Springer Publishing Company, Inc.; 2007. 58. Rojas G, Fritsch R, Solis J, Jadresic E, Castillo C, González M, et al. Treatment of postnatal depression in low-income mothers in primary-care clinics in Santiago, Chile: a randomised controlled trial. Lancet 2007;370:1629–37. 59. Milgrom J, Negri LM, Gemmill AW, McNeil M, Martin PR. A randomized controlled trial of psychological interventions for postnatal depression. Br J Clin Psychol 2005;44:529–42. 60. Highet N, Drummond P. A comparative evaluation of community treatments for postpartum depression: implications for treatment and management practices. Aust N Z J Psychiatry 2004;38:212–18. 61. Clark R, Tluczek A, Wenzel A. Psychotherapy for postpartum depression: a preliminary report. Am J Orthopsychiatry 2003;73:441–54. 62. Meager I, Milgrom J. Group treatment for postpartum depression: A pilot study. Aust N Z J Psychiatry 1996;30:852–60. 63. Wampold BE, Brown GS. Estimating variability in outcomes attributable to therapists: A naturalistic study of outcomes in managed care. J Consult Clin Psychol 2005;73:914–23. 64. Popay J, Rogers A, Williams G. Rationale and standards for the systematic review of qualitative literature in health services research. Qual Health Res 1998;8:341–51. 65. Duskin C. Experiences of social comparison in a postpartum depression support group. Dissertation Abstracts International: Section B: The Sciences and Engineering 2006;67:539. 66. Beck C. Teetering on the edge: A substantive theory of postpartum depression. Nurs Res 1993;42:42–8. 67. Pitts F. Professional. Health visiting: the Monday group: postnatal depression revisited. Community Pract 1999;72:327–9. 68. Eastwood P. Group work 1. Promoting peer group support with postnatally depressed women. Health Visit 1995;68:148–50. 69. Najavits LM, Weiss RD. Variations in therapist effectiveness in the treatment of patients with substance use disorders: An empirical review. Addiction 1994;89:679–88. 70. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 1996;313:275–83. 71. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisals. 2008. URL: www.nice.org.uk/media/ B52/A7/TAMethodsGuideUpdatedJune2008.pdf (accessed 1 April 2009). 72. Brazier JE, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF- 36. J Health Econ 2002;21:271–92. 73. Briggs A, Claxton K, Sculpher M. Decision modelling for health economic evaluation. Oxford: Oxford University Press; 2006. 74. Claxton K, Sculpher M, McCabe C, Briggs A, Akehurst R, Buxton M. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ 2005;14:339–47. 75. Stinnett A, Mulahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analyses. Med Decis Making 1998;18:S68–S80. 76. Office for National Statistics. Births and deaths. London: Office for National Statistics; 2004. 77. Schafer JL. Analysis of incomplete multivariate data. London: Chapman and Hall; 1997. 78. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res 1999;8:3–15. 79. Tanner BA. A multidimensional client satisfaction instrument. Eval Program Plann 1982;5:161–7.
URI:	http://wrap.warwick.ac.uk/id/eprint/37403

Request changes to a record

Actions (login required)

View Item